Edit |   |
---|---|
Antigenic Specificity | Ranibizumab |
Clone | monoclonal |
Host Species | Recombinant Humanized |
Reactive Species | n/a |
Isotype | n/a |
Format | unconjugated |
Size | n/a |
Concentration | n/a |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Ranibizumab is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment designed for intraocular use. Ranibizumab binds to and inhibits the biologic activity of human vascular endothelial growth factor A (VEGF-A). Ranibizumab has a molecular weight of approximately 48 kilodaltons and is produced by an E. coli expression system in a nutrient medium containing the antibiotic tetracycline (tetracycline is not detectable in the final product). Ranibizumab is marketed under the name ranibizumab. It is indicated for the treatment of macular edema after retinal vein occlusion, age-related macular degeneration (wet), and diabetic macular edema. |
Immunogen | n/a |
Other Names | n/a |
Gene, Accession # | n/a |
Catalog # | TP-104CL |
Price | please inquire |
Order / More Info | Ranibizumab Antibody from CREATIVE BIOLABS, INC. |
Product Specific References | n/a |